PlexusDx maps 14 metabolic and appetite pathways, including FTO rs9939609 and MC4R rs17782313, to forecast your weight loss potential and medication compatibility
What this changes and what it doesnt This is not a reason to avoid GLP-1 agents
They also tend to show up in a DEXA scan rather than a mirror, which is why most women don't connect the symptoms to the weight loss until something more dramatic - a fracture from a minor fall, for example - forces the issue
The development of generic alternatives of GLP-1 agonists by several pharma companies increases the accessibility for many people, helping them to reduce weight
But data dont support the ability to wean off. Media Contact: Brian Donohue - 206-457-9182, [email protected] Creatas Video+ / Getty Images Plus A package of injection pens for semaglutide, a drug that mimics a gut hormone that regulates blood sugar and decreases appetite
Actual dosing and pricing may vary depending on your treatment plan